Cornea, Global Ophthalmology, Sustainability

Corneal Surgery’s Contribution to Climate Change

Keratoplasty’s impact on greenhouse gases is greater than many might suspect.

Corneal Surgery’s Contribution to Climate Change
Andrew Sweeney
Published: Monday, September 1, 2025
“ SF₆ has a significant carbon footprint despite its clinical benefits. “

The fight against climate change involves ophthalmology as much as, or more than, other medical specialties. The effect of fluorinated gases used in keratoplasty procedures may have a greater impact than many might suspect, according to Matteo Airaldi MD.

“We know that healthcare contributes significantly to greenhouse gas emissions. In particular, in the UK, 5.5% of the country’s emissions are attributed to the national healthcare system,” said Dr Airaldi, presenting on behalf of Alfredo Borgia MD.

“In ophthalmology, fluorinated gases used during surgery are the main contributors to greenhouse gases. These include sulphur hexafluoride (SF6), hexafluoroethane (C2F6), and octafluoropropane (C3F8).”

Describing these gases as having a “high global warming potential,” he said they are used in routine procedures, including vitreoretinal surgery and endothelial keratoplasty. To understand their full impact on the environment, Drs Borgia and Airaldi evaluated the carbon emissions originating from the latter procedure.

Their research was organised as a retrospective single-centre study at the Royal Liverpool University Hospital between 2022 and 2024 and involved 357 endothelial keratoplasty cases. These included Descemet membrane endothelial keratoplasty (DMEK), ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK), and rebubbling.

In total, 160 DMEK procedures (44.8%) were performed, 118 (33.1%) UT-DSAEK, and 79 (22.1%) rebubbling.

Equivalent CO2 was calculated according to data provided by the Intergovernmental Panel on Climate Change (IPCC), and both 15 mL and 30 mL canisters of fluorinated gases were used. SF6 gas at a concentration of 20% was used during the DMEK and UT-DSAEK procedures; however, the rebubbling procedures used a combination, including air.

The study found that the total number of procedures in the study emitted 1.5 tonnes of CO2 over three years, equivalent to approximately “14,000 kilometres driven by an average car.” SF6 30 mL emitted 4.93 kg of CO2 per canister over the same period, equivalent to four times that of C2F6 or C3F8 15-mL canisters, whereas 15-mL canisters of SF6 emitted 2.46 kg of CO2.

“SF6 has a significant carbon footprint despite its clinical benefits; it’s responsible for four times as many emissions as other fluorinated gases we considered. The smaller, 15-mL canisters are more efficient, especially C2F6 and C3F8,” Dr Airaldi said.

“Using an air tamponade for rebubbling may be sustainable in low-risk cases. Reusing canisters that have undergone filtration could be considered, where safe and permitted.”

The researchers concluded with a call to action to ophthalmic surgeons to consider how they can integrate eco-conscious choices in corneal surgery without compromising patient care. They highlighted the current policy of utilising disposable, single-use canisters as being particularly problematic, as alluded to in their study’s findings.

“We can reduce the environmental impact of corneal surgery by preferring smaller canisters, choosing alternative gases or air, and by advocating for more sustainable packaging. We might also have the possibility of reusing gases from larger cylinders,” Dr Airaldi said.

Dr Airaldi presented on behalf of Dr Borgia at the 2025 EuCornea conference in Prague.

 

 

Matteo Airaldi MD is a doctoral candidate at the University of Brescia, Italy. matteo.airaldi@unibs.it

Alfredo Borgia MD, FEBO is a cornea consultant at the “Mons. Dimiccoli” Teaching Hospital, Barletta, Italy. alfredo.borgia@aslbat.it

 

Tags: cornea, sustainability, climate change, corneal surgery, keratoplasty, Matteo Airaldi, Alfredo Borgia, sustainable practices, DMEK, UT-DSAEK
Latest Articles
Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...

Should Fuchs’ Dystrophy Patients Get Premium Lenses?

Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.

Read more...

Avoiding Posterior Capsule Rupture

Imaging may help, but surgical technique is key for managing posterior polar cataracts.

Read more...

The Philosophy of Innovation

Deluded personality essential for initiating and completing the journey.

Read more...